Related Experiment Video

Updated: Jun 12, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma

Bogusz Trojanowicz1, Carsten Sekulla, Kerstin Lorenz

  • 1Universitätsklinik und Poliklinik für Allgemein-, Viszeral- und Gefässchirurgie, Martin-Luther Universität, 06097 Halle, Germany.

Molecular and Cellular Endocrinology
|June 12, 2010
PubMed

Insights

Retinoic acid (RA) reduces key proteins like ENO1 and GAPDH, decreasing thyroid cancer cell vitality. These proteins are elevated in thyroid tumors, suggesting new therapeutic targets for RA treatment.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Retinoic acid (RA) previously reduced ENO1 and c-Myc, decreasing thyroid cancer cell invasiveness.
  • Understanding RA's broader molecular effects is crucial for thyroid cancer therapy.

Purpose of the Study:

  • To identify proteins affected by RA treatment in follicular thyroid carcinoma cells.
  • To investigate the expression of these proteins in various thyroid carcinoma tissues.

Main Methods:

  • Two-dimensional electrophoresis and mass spectrometry were used to identify RA-affected proteins.
  • Quantitative analysis of specific protein levels in cell lines and thyroid tissues.

Main Results:

  • RA significantly reduced ENO1, GAPDH, PKM1/M2, PPIA, TKT, ANXA2, GSTP1, and PRDX2 in thyroid cancer cells.
  • These proteins were significantly upregulated in follicular, papillary, and undifferentiated thyroid carcinomas compared to benign thyroid tissues.

Conclusions:

  • RA targets multiple glycolytic and cellular stress proteins, impacting thyroid cancer cell behavior.
  • Identified proteins represent potential therapeutic targets for RA-mediated anti-tumor and re-differentiation strategies in thyroid carcinoma.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...